CONMED Corporation (CNMD)

Gross profit margin

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Gross profit (ttm) US$ in thousands 676,245 625,932 609,488 590,575 571,245 595,239 585,930 575,577 568,035 547,693 539,085 469,590 460,300 466,761 463,174 522,435 524,714 515,394 495,910 480,991
Revenue (ttm) US$ in thousands 1,244,743 1,168,565 1,139,075 1,098,613 1,045,472 1,068,575 1,042,314 1,020,285 1,010,635 989,493 978,501 881,125 862,458 874,495 870,250 950,728 955,096 932,675 901,392 875,949
Gross profit margin 54.33% 53.56% 53.51% 53.76% 54.64% 55.70% 56.21% 56.41% 56.21% 55.35% 55.09% 53.29% 53.37% 53.37% 53.22% 54.95% 54.94% 55.26% 55.02% 54.91%

December 31, 2023 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $676,245K ÷ $1,244,743K
= 54.33%

Conmed Corp.'s gross profit margin has exhibited a declining trend over the past eight quarters, from 56.41% in Q1 2022 to 54.33% in Q4 2023. This downward trend may indicate challenges in maintaining profitability on manufacturing and selling its products. Despite the decrease, the gross profit margin has generally remained above 50% throughout the period, suggesting that Conmed Corp. has been able to effectively manage its production costs relative to its sales revenue. Further analysis of the company's operational efficiency and pricing strategies may provide insights into the factors influencing this trend in gross profit margin.


Peer comparison

Dec 31, 2023